
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.
Charlotte's Web Holdings, Inc. trades as CWEB.TO on TSX. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in CAD.
The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $49.90M of revenue and -$29.74M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Charlotte's Web Holdings, Inc. can be compared against peers such as Avicanna Inc., BriaCell Therapeutics Corp., Greenway Greenhouse Cannabis Corporation, Izotropic Corporation, MediPharm Labs Corp., Perimeter Medical Imaging AI, Inc..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $88.33M, beta of 2.24, and return on equity of +1458.6%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
CWEB.TO currently shows total debt of $64.45M and beta of 2.24. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.charlottesweb.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.